Cyproterone acetate EP Impurity A
CAS: 2701-50-0
Ref. 3D-IC180619
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire | |
| 250mg | To inquire |
Product Information
- (1β,2β)-17-(Acetyloxy)-1,2-dihydro-3′H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione
- 17α-Hydroxy-1α,2α-Methylenepregna-4,6-Diene-3,20-Dione-17-Acetate
- 1α,2α-Methylene-3,20-dioxo-pregna-4,6-dien-17α-acetoxy
- 3′H-Cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione, 17-(acetyloxy)-1,2-dihydro-, (1β,2β)-
- 3′H-Cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione, 1β,2β-dihydro-17-hydroxy-, acetate
- Cyclopropa[1,2]cyclopenta[a]phenanthrene, 3′H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione deriv.
- Pregna-4,6-diene-3,20-dione, 17-hydroxy-1α,2α-methylene-, acetate
Cyproterone acetate EP Impurity A is a metabolite of cyproterone acetate. Cyproterone acetate is an androgen receptor antagonist drug product which is used in the treatment of prostate cancer and male pattern hair loss. Cyproterone acetate EP Impurity A has been found to be toxic to rats when administered orally, with LD50 values of 40-120 mg/kg, depending on the study. It also has been shown to inhibit hepatic p450 enzymes in rats after oral administration.
Cyproterone acetate EP Impurity A is an impurity standard for cyproterone acetate and is available as a pure compound or as a custom synthesis. This impurity can be analyzed using HPLC with UV detection at 210 nm or by GC with flame ionization detection at 230°C. The purity of this compound can be confirmed using NMR spectroscopy, melting point determination, or elemental analysis.END>
NAME
Chemical properties
Technical inquiry about: 3D-IC180619 Cyproterone acetate EP Impurity A
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
